Furthermore, A comprehensive study by Mok et al., involving 539 SLE patients, corroborated previous findings, exploring the correlation between blood PCSK9 levels, disease activity, and major adverse cardiovascular events (MACEs). This evidence concerns the gene PCSK9 and systemic lupus erythematosus.